计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
TAK-593 is a potent VEGFR and PDGFR family inhibitor with IC 50 s of 3.2, 0.95, 1.1, 4.3 and 13 nM for VEGFR1, VEGFR2, VEGFR3, PDFGRα and PDFGRβ, respectively.
In Vitro
TAK-593 inhibits growth of HUVEC with an IC 50 of 0.30 nM. It shows potent inhibitory activity against VEGFR (VEGFR1-3: IC 50 =3.2, 0.95, 1.1 nM) and PDGFR (PDGFRα, β: IC 50 =4.3, 13 nM) families. Against other kinases, the IC 50 values of TAK-593 are above 100 nM, except for Fms (IC 50 =10 nM) and Ret (IC 50 =18 nM) kinases. TAK-593 potently inhibits VEGF- and PDGF-stimulated cellular phosphorylation and proliferation of human umbilical vein endothelial cells and human coronary artery smooth muscle cells. TAK-593 also potently inhibits VEGF-induced tube formation of endothelial cells co-cultured with fibroblasts. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
TAK-593 inhibits growth of HUVEC with an IC 50 of 0.30 nM. It shows potent inhibitory activity against VEGFR (VEGFR1-3: IC 50 =3.2, 0.95, 1.1 nM) and PDGFR (PDGFRα, β: IC 50 =4.3, 13 nM) families. Against other kinases, the IC 50 values of TAK-593 are above 100 nM, except for Fms (IC 50 =10 nM) and Ret (IC 50 =18 nM) kinases . TAK-593 potently inhibits VEGF- and PDGF-stimulated cellular phosphorylation and proliferation of human umbilical vein endothelial cells and human coronary artery smooth muscle cells. TAK-593 also potently inhibits VEGF-induced tube formation of endothelial cells co-cultured with fibroblasts. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:VEGFR1 3.2 nM (IC 50 ) VEGFR2 0.95 nM (IC 50 ) VEGFR3 1.1 nM (IC 50 ) PDGFRα 4.3 nM (IC 50 ) PDGFRβ 13 nM (IC 50 ) PDGFRα V561D 1 nM (IC 50 )
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 苯胺类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 芳香族苯胺 |
| 其他上位类(Alternative Parents) | 二芳醚 2-杂芳基酰胺 N-芳基酰胺 酚醚 苯氧基化合物 吡唑-5-甲酰胺 甲苯 N-取代咪唑 咪唑内酰胺类 环丙烷羧酸及其衍生物 哒嗪及其衍生物 杂芳族化合物 仲羧酸酰胺 氮杂环化合物 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 2-异芳基甲酰胺 - 芳香族苯胺 - 芳香族杂多环化合物 - 氮杂环 - 吡唑 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 环丙烷羧酸或其衍生物 - 二芳基醚 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 咪唑 - 咪唑内酰胺 - N-芳基酰胺 - N-取代咪唑 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 苯酚醚 - 苯氧基化合物 - 吡唑 - 吡唑-5-甲酰胺 - 吡嗪 - 醛基 - 甲苯 |
| 描述(Description) | 该化合物属于芳香族苯胺类有机化合物。这类芳香化合物含有苯胺基团,其中羧酰胺基被芳香基团取代。其通式为RNC(=O)R',其中R=苯基,R=芳香族基团。 |
| 外部描述符(External Descriptors) | 暂无 |
| ALogP | 2.4 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|